| Application no. and date | 16725104.0 (espacenet) (Federated) (European Patent Register), 20160523 | | Patent/reg. no. and date | DK/EP 3302549, 20190703 | | Publication date | 20180411 | | Priority no. and date | EP 15169199, 20150526 | | EP pub. no. and date |
EP 3302549 20180411 | | Effective date | | | Applicant/owner | F. HOFFMANN-LA ROCHE AG, 124 Grenzacherstrasse
4070 Basel, CH | | Applicant ref. no. | P69490DK01 | | Inventor | HERTING, Frank, An der Freiheit 29a
82377 Penzberg, DE,
DANGL, Markus, Unterer Flurweg 7
82402 Seeshaupt, DE,
KLEIN, Christian, Chapfstrasse 26B
8906 Bonstetten, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/40 (2006.01) , A61K 31/496 (2006.01) , A61K 39/395 (2006.01) , A61P 35/02 (2006.01) , C07K 16/28 (2006.01) | | Title | Kombinationsbehandling af et anti-CD20-antistof med en Bcl-2-inhibitor og en MDM2-inhibitor | | Int. application no. | EP2016061517 | | Int. publication no. | WO2016188935 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
